Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

procarbazine/thalidomide

Known as: PCB/THAL 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Cyclin-dependent kinase 9 (CDK9), an important regulator of transcriptional elongation, is a promising target for cancer therapy… 
2014
2014
Multiple myeloma (MM) accounts for 1% of all types of cancer and for 2% of all cancer deaths. These numbers are approximately 13… 
  • table 1
2013
2013
INTRODUCTION hemoglobinopathies constitute a major health problem worldwide. These disorders are characterized by a clinical and… 
  • table 1
  • table 2
  • figure 1
2008
Review
2007
Review
2007
This paper summarizes the results on the epidemiology and molecular basis of thalassemias and other hemoglobinopathies in the… 
2006
2006
In a recent study, it was reported that thalidomide may suppress mucosal, cutaneous and articular manifestations in the major i… 
  • table 1
  • table I
2004
2004
Sight threatening changes in the retina are a well-recognized complication of sickle cell disease (SCD). However they usually… 
  • table 1
1987
1987
The purpose of this study was to ascertain whether thalassemia heterozygotes (α thal) who have sickle cell anemia (SCA) suffer… 
Highly Cited
1985
Highly Cited
1985
La thalidomide, administree a 6 hommes volontaires sains, entraine une diminution du rapport cellules T. auxiliaires/cellules T… 
  • figure 1
1969
1969
Thalidomide treatment of patients suffering from leprosy reaction (LR ) was introduced in 1964 (3). This thcrapy has a striking… 
  • figure 2